Nanomedicine

Search results

• Major EU grants for groundbreaking research into scoliosis and transplant organ rejection

  Mulder, W.

  22/04/21

  1 item of Media coverage

  Press/Media

• TTXD appoints Nobel Laureate Dr. James Allison, Dr. Padmanee Sharma, and Dr. Mihai Netea to Scientific Advisory Board

  Mulder, W.

  19/04/21

  1 item of Media coverage

  Press/Media

• TTXD appoints Nobel Laureate Dr. James Allison, Dr. Padmanee Sharma, and Dr. Mihai Netea to Scientific Advisory Board

  Mulder, W.

  19/04/21

  1 item of Media coverage

  Press/Media

• TTXD appoints Nobel Laureate Dr. James Allison, Dr. Padmanee Sharma, and Dr. Mihai Netea to Scientific Advisory Board

  Mulder, W.

  19/04/21

  1 item of Media coverage

  Press/Media

• TTXD appoints Nobel Laureate Dr. James Allison, Dr. Padmanee Sharma, and Dr. Mihai Netea to Scientific Advisory Board

  Mulder, W.

  19/04/21

  2 items of Media coverage

  Press/Media

• Trained Therapeutix Discovery Inc. Appoints Dr. Willem Mulder as Chief Scientific Officer

  Mulder, W., Ochando, J. & Fayad, Z.

  5/01/21

  1 item of Media coverage

  Press/Media

• Trained Therapeutix Discovery Inc. Appoints Dr. Willem Mulder as Chief Scientific Officer

  Mulder, W., Ochando, J. & Fayad, Z.

  5/01/21

  1 item of Media coverage

  Press/Media

• Nanoparticle Trains Immune Cells To Attack Cancer

  Mulder, W.

  30/12/20

  1 item of Media coverage

  Press/Media

• Nanoparticle Trains Immune Cells to Attack Cancer

  Mulder, W.

  4/12/20

  1 item of Media coverage

  Press/Media

• Nanoparticle Trains Immune Cells to Attack Cancer

  Mulder, W.

  4/12/20

  1 item of Media coverage

  Press/Media

• Trained Therapeutix Discovery Inc.'s Exclusively Licensed Technology Shown to Suppress Cancer Growth

  Mulder, W. & Fayad, Z.

  2/11/20

  1 item of Media coverage

  Press/Media

• Trained Therapeutix Discovery Inc.'s Exclusively Licensed Technology Shown to Suppress Cancer Growth

  Mulder, W. & Fayad, Z.

  2/11/20

  1 item of Media coverage

  Press/Media

• Novel nanobiologic trains immunity, curbs tumor growth in mice

  Mulder, W.

  2/11/20

  1 item of Media coverage

  Press/Media

• Trained Therapeutix Discovery 's Exclusively Licensed Technology Shown to Suppress Cancer Growth

  Mulder, W., Ochando, J. & Fayad, Z.

  2/11/20

  1 item of Media coverage

  Press/Media

• Trained Therapeutix Discovery Inc.’s Exclusively Licensed Technology Shown to Suppress Cancer Growth

  Mulder, W. & Fayad, Z.

  2/11/20

  1 item of Media coverage

  Press/Media

• -Eindhoven University of Technology: Ground-breaking study on trained immunity to fight cancer

  Mulder, W.

  2/11/20

  1 item of Media coverage

  Press/Media

• Training the innate immune system to fight cancer

  Mulder, W.

  30/10/20

  1 item of Media coverage

  Press/Media

• Eindhoven University of Technology: Ground-Breaking Study on Trained Immunity to Fight Cancer

  Mulder, W.

  30/10/20

  1 item of Media coverage

  Press/Media

• Groundbreaking study on trained immunity to fight cancer

  Mulder, W.

  29/10/20

  4 items of Media coverage

  Press/Media

• -Eindhoven University of Technology: New understanding in how hydroxychloroquine works undermines its use for corona

  Mulder, W.

  18/06/20

  1 item of Media coverage

  Press/Media

• New understanding in how hydroxychloroquine works undermines its use for coronavirus

  Mulder, W.

  18/06/20

  1 item of Media coverage

  Press/Media

• Eindhoven University of Technology: New Understanding in How Hydroxychloroquine Works Undermines Its Use for Corona

  Mulder, W.

  18/06/20

  1 item of Media coverage

  Press/Media

• Malaria drug Hydroxychloroquine appears to block ‘trained immunity’ – which undermines its use for corona

  Mulder, W.

  17/06/20

  1 item of Media coverage

  Press/Media

• New understanding in how hydroxychloroquine works undermines its use for corona

  Mulder, W.

  17/06/20

  1 item of Media coverage

  Press/Media

• Australia Patent: Stichting Katholieke Universiteit, Icahn School of Medicine at Mount Sinai File Application for 'Promoting trained immunity with therapeutic nanobiologic compositions'

  Mulder, W., Ochando, J. & Fayad, Z.

  5/06/20

  1 item of Media coverage

  Press/Media